Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Travere Therapeutics, Inc. | 35,655 | reported | 11 May 2022 | tx 66+688,573−82,218 |
| STANDARD BIOTOOLS INC. | 35,380 | reported | 14 Jun 2023 | tx 13+240,933 |
| Genasys Inc. | 0 | reported | 27 Apr 2022 | tx 34+684,883−188,572 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Jun 2023 | GRANT_AWARD | STANDARD BIOTOOLS INC. | 26,376 | 0.00 USD | |
| 14 Jun 2023 | GRANT_AWARD | STANDARD BIOTOOLS INC. | 35,380 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | STANDARD BIOTOOLS INC. | 30,914 | 0.00 USD | |
| 15 Jun 2022 | GRANT_AWARD | STANDARD BIOTOOLS INC. | 42,571 | 0.00 USD | deriv |
| 10 May 2022 | SALE | Travere Therapeutics, Inc. | 825 | 21.51 USD | |
| 11 May 2022 | SALE | Travere Therapeutics, Inc. | 1,375 | 21.51 USD | |
| 27 Apr 2022 | EXERCISE | Genasys Inc. | 50,000 | 1.33 USD | |
| 27 Apr 2022 | EXERCISE | Genasys Inc. | 50,000 | 0.00 USD | deriv |
| 15 Mar 2022 | GRANT_AWARD | Genasys Inc. | 30,000 | — | |
| 23 Feb 2022 | EXERCISE | Genasys Inc. | 20,000 | 2.16 USD | |
| 23 Feb 2022 | SALE | Genasys Inc. | 13,716 | 3.14 USD | |
| 23 Feb 2022 | EXERCISE | Genasys Inc. | 20,000 | 0.00 USD | deriv |
| 31 Jan 2022 | GRANT_AWARD | Travere Therapeutics, Inc. | 9,840 | 0.00 USD | |
| 31 Jan 2022 | SALE | Travere Therapeutics, Inc. | 1,238 | 27.40 USD | |
| 31 Jan 2022 | GRANT_AWARD | Travere Therapeutics, Inc. | 39,360 | 0.00 USD | deriv |
| 31 Jan 2022 | GRANT_AWARD | Travere Therapeutics, Inc. | 9,840 | 0.00 USD | deriv |
| 31 Jan 2022 | GRANT_AWARD | Travere Therapeutics, Inc. | 8,000 | 0.00 USD | deriv |
| 24 Jan 2022 | SALE | Travere Therapeutics, Inc. | 2,063 | 24.98 USD | |
| 10 Jan 2022 | GRANT_AWARD | Travere Therapeutics, Inc. | 7,500 | 0.00 USD | |
| 11 Jan 2022 | SALE | Travere Therapeutics, Inc. | 7,500 | 27.40 USD | |
| 17 Aug 2021 | SALE | Travere Therapeutics, Inc. | 1,407 | 17.12 USD | |
| 13 Aug 2021 | GRANT_AWARD | Travere Therapeutics, Inc. | 4,500 | 0.00 USD | |
| 25 May 2021 | GRANT_AWARD | STANDARD BIOTOOLS INC. | 10,342 | 0.00 USD | |
| 25 May 2021 | GRANT_AWARD | STANDARD BIOTOOLS INC. | 15,402 | 0.00 USD | deriv |
| 12 May 2021 | SALE | Travere Therapeutics, Inc. | 2,000 | 19.46 USD |